Boosting Africa's capacity to manufacture vaccines

NewsGuard 100/100 Score

Africa produces only one per cent of its routine vaccines. This leaves the region dependent on imports for its vaccine needs, and makes it vulnerable to a vaccine crisis during health emergencies.

In this episode of Africa Science Focus, Ebere Okereke, senior technical advisor at the Tony Blair Institute for Global Change and honorary senior public health advisor for the Africa Centres for Disease Control and Prevention, says research in science, and funding for therapeutics and vaccine manufacturing in the continent, must increase.

Professor Claude Muvunyi, director general for the Rwanda Biomedical Centre, tells us that boosting Africa's capacity to manufacture vaccines will be a front burner discussion during the 2nd International Conference on Public Health in Africa, scheduled to take place in Rwanda on the second week of December.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseases